Literature DB >> 16873070

New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors.

E Camilla Forsberg1, Thomas Serwold, Scott Kogan, Irving L Weissman, Emmanuelle Passegué.   

Abstract

A model of hematopoietic development wherein multipotentiality is conserved until segregation of myeloid and lymphoid potential has recently been challenged, proposing that megakaryocyte/erythrocyte (MegE) potential is lost in Flk2/Flt3-expressing early progenitors. Here, we used sensitive in vivo approaches to quantitatively and kinetically assess the MegE potential of hematopoietic stem cells and various Flk2(+) early progenitors and compared it with the MegE potential of downstream committed myeloid and lymphoid progenitors and with their ability to give rise to mature myelomonocytic and lymphoid cells. We demonstrate that Flk2(+) early progenitors retain MegE potential in vivo both at the population and clonal levels. These results indicate that Flk2 expression by early progenitors is not at the expense of full multipotency and support the current model of hematopoietic development with segregation of myeloid and lymphoid lineages from multipotent progenitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873070     DOI: 10.1016/j.cell.2006.06.037

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  91 in total

1.  Cholinergic activation of hematopoietic stem cells: role in tobacco-related disease?

Authors:  Edwin Chang; E Camilla Forsberg; Jenny Wu; Susan S Prohaska; Rich Allsopp; Irving L Weissman; John P Cooke
Journal:  Vasc Med       Date:  2010-10       Impact factor: 3.239

Review 2.  Hematopoietic stem cell: self-renewal versus differentiation.

Authors:  Jun Seita; Irving L Weissman
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

3.  Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis.

Authors:  Joanne L Attema; Peter Papathanasiou; E Camilla Forsberg; Jian Xu; Stephen T Smale; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

Review 4.  Advancing insights into stem cell niche complexities with next-generation technologies.

Authors:  Nicholas Heitman; Nivedita Saxena; Michael Rendl
Journal:  Curr Opin Cell Biol       Date:  2018-07-19       Impact factor: 8.382

5.  Novel role for EKLF in megakaryocyte lineage commitment.

Authors:  Pilar Frontelo; Deepa Manwani; Mariann Galdass; Holger Karsunky; Felix Lohmann; Patrick G Gallagher; James J Bieker
Journal:  Blood       Date:  2007-08-22       Impact factor: 22.113

6.  The adhesion molecule esam1 is a novel hematopoietic stem cell marker.

Authors:  A G Lisa Ooi; Holger Karsunky; Ravindra Majeti; Stefan Butz; Dietmar Vestweber; Tatsuro Ishida; Thomas Quertermous; Irving L Weissman; E Camilla Forsberg
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

7.  A Transient Developmental Hematopoietic Stem Cell Gives Rise to Innate-like B and T Cells.

Authors:  Anna E Beaudin; Scott W Boyer; Jessica Perez-Cunningham; Gloria E Hernandez; S Christopher Derderian; Chethan Jujjavarapu; Eric Aaserude; Tippi MacKenzie; E Camilla Forsberg
Journal:  Cell Stem Cell       Date:  2016-09-22       Impact factor: 24.633

Review 8.  The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles.

Authors:  Peter J Quesenberry; Jason M Aliotta
Journal:  Stem Cell Rev       Date:  2008-07-30       Impact factor: 5.739

9.  MLL5 contributes to hematopoietic stem cell fitness and homeostasis.

Authors:  Yan Zhang; Jasmine Wong; Mark Klinger; Mary T Tran; Kevin M Shannon; Nigel Killeen
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

10.  In vivo evidence for an instructive role of fms-like tyrosine kinase-3 (FLT3) ligand in hematopoietic development.

Authors:  Panagiotis Tsapogas; Lee Kim Swee; Anja Nusser; Natko Nuber; Matthias Kreuzaler; Giuseppina Capoferri; Hannie Rolink; Rhodri Ceredig; Antonius Rolink
Journal:  Haematologica       Date:  2014-01-24       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.